On Monday, Editas Medicine Inc (NASDAQ: EDIT) was -3.42% drop from the session before settling in for the closing price of $1.46. A 52-week range for EDIT has been $1.12 – $8.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 96.99% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 48.61%. With a float of $82.23 million, this company’s outstanding shares have now reached $82.73 million.
In an organization with 246 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 86.3%, operating margin of -777.25%, and the pretax margin is -733.74%.
Editas Medicine Inc (EDIT) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Editas Medicine Inc stocks. The insider ownership of Editas Medicine Inc is 0.91%, while institutional ownership is 62.52%. The most recent insider transaction that took place on Mar 04 ’25, was worth 7,030. In this transaction EVP, CHIEF FINANCIAL OFFICER of this company sold 4,109 shares at a rate of $1.71, taking the stock ownership to the 112,720 shares. Before that another transaction happened on Mar 04 ’25, when Company’s CEO sold 16,632 for $1.71, making the entire transaction worth $28,452. This insider now owns 295,474 shares in total.
Editas Medicine Inc (EDIT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.95% during the next five years compared to -1.48% drop over the previous five years of trading.
Editas Medicine Inc (NASDAQ: EDIT) Trading Performance Indicators
You can see what Editas Medicine Inc (EDIT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.75. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.88, a number that is poised to hit -0.56 in the next quarter and is forecasted to reach -1.05 in one year’s time.
Technical Analysis of Editas Medicine Inc (EDIT)
Let’s dig in a bit further. During the last 5-days, its volume was 2.25 million. That was inferior than the volume of 4.31 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 7.67%. Additionally, its Average True Range was 0.25.
During the past 100 days, Editas Medicine Inc’s (EDIT) raw stochastic average was set at 10.82%, which indicates a significant increase from 10.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 116.69% in the past 14 days, which was lower than the 157.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5040, while its 200-day Moving Average is $3.1586. However, in the short run, Editas Medicine Inc’s stock first resistance to watch stands at $1.4633. Second resistance stands at $1.5167. The third major resistance level sits at $1.5933. If the price goes on to break the first support level at $1.3333, it is likely to go to the next support level at $1.2567. The third support level lies at $1.2033 if the price breaches the second support level.
Editas Medicine Inc (NASDAQ: EDIT) Key Stats
There are 82,976K outstanding shares of the company, which has a market capitalization of 117.00 million. As of now, sales total 32,310 K while income totals -237,090 K. Its latest quarter income was 30,610 K while its last quarter net income were -45,390 K.
